Physician profile
Larry Thomas
NPI 1386168524
$361.21
in general payments reported to CMS, 2019-2025
9 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.95 · 2022: $62.04 · 2023: $56.43 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $117.04 | 2025 | Senza |
| Astellas Pharma US INC | $99.95 | 2021 | |
| Pfizer INC. | $28.71 | 2023 | |
| Novo Nordisk INC | $28.47 | 2022-2023 | Wegovy |
| Spr Therapeutics, INC | $25.75 | 2025 | Sprint Pns System |
| Bayer Healthcare Pharmaceuticals INC. | $20.26 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.73 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.01 | 2023 | Xifaxan |
| Idorsia Pharmaceuticals US INC | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.